by William Jester | Sep 22, 2022 | Community, Covid, News
The National Institute of Allergy and Infectious Diseases (NIAID) has earmarked $600 million to stop future pandemics before they start – and up to $3.8 million of that will go to a team led by Rutgers researcher Eddy Arnold. The plan is simple: Identify viruses with...
by William Jester | Sep 18, 2022 | Community, Covid, News
A new study is sure to add another layer of intrigue surrounding Pfizer’s COVID-19 pill Paxlovid. In the study, based on data collected from 109,000 patients at a large Israeli health system, the drug appeared highly effective in seniors. Researchers found that those...
by William Jester | Sep 17, 2022 | Community, Covid, News
Hospitalized patients on high-flow oxygen for severe COVID-19 pneumonia were nearly 50 percent less likely to die when baricitinib was added to the antiviral remdesivir and the steroid dexamethasone, according to Rutgers research. “All three of the medications work in...
by William Jester | Sep 15, 2022 | Community, Covid, News
The situation around the current spread of COVID-19 is changing rapidly. We have compiled resource links for the general community highlighting local resources across New Jersey, ways to get involved, and mental and physical wellness. Visit our COVID-19 page for...
by Pamela Dahlen | Sep 3, 2022 | Community, Covid, News
According to a recent poll by NPR, the Robert Wood Johnson Foundation and the Harvard T.H. Chan School of Public Health, among households that had a serious illness in the past year, one in five respondents said they had trouble accessing care during the pandemic. ...
